Drug recall
AMMONIUM MOLYBDATE INJECTION, USP, Molybdenum 250 mcg/10 mL (25 mcg/mL), 10 mL single dose vial, packaged in…
FDA recall event 58714 · Class II · Luitpold Pharmaceuticals, Inc.
Key facts
| Event ID | 58714 |
|---|---|
| Recall numbers | D-596-2011 |
| Recalling firm | Luitpold Pharmaceuticals, Inc. |
| Product type | Drugs |
| Products | AMMONIUM MOLYBDATE INJECTION, USP, Molybdenum 250 mcg/10 mL (25 mcg/mL), 10 mL single dose vial, packaged in 25 x 10 mL single dose vials per tray pack, Rx Only, AMERICAN REGENT, INC. SHIRLEY, NY… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Presence of Particulate Matter: Visual particulate matter was observed in retain and stability samples of Ammonium Molybdate Injection, USP, 10 mL vial, Lot 9409. |
| Initiation date | Apr 26, 2011 |
| Termination date | Jun 28, 2018 |
| City | Shirley |
| State | NY |
| Country | United States |
| FEI number | 2410375 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports